24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
ScaleUp House
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
Corporate
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Opthamology
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
ScaleUp House
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
Corporate
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
23:35
Anthropic prices IPO at $83, valuing Claude maker at $1.5 trillion
23:24
Palo Alto Networks jumps after earnings beat and $4.5 billion AI acquisition
22:06
"In the AI era, cyber needs to be thought of in terms of tasks rather than products or tools"
21:59
"Today it's not enough to block an agent, you need to explain to it why you did so"
More stories
Buzz
Most popular
Daily
Weekly
1
After years in development, Elbit's airborne laser weapons move closer to production
2
The Israeli business Nvidia bought for $6.9 billion now generates $21 billion a quarter
3
Intel employees report new IT layoffs as restructuring continues
4
Colette Kress helped bring Israel to the heart of Nvidia's AI business. Now she's in charge.
5
Amazon set to seal Decart deal worth up to $7.5 billion within days
More news
Opthamology
4 stories about Opthamology
How one female CEO overcame adversity to find a cure for Uveitis
04.02.22
|
Roni Dori
"I see us building a large company that will focus on the eye, beyond Uveitis. Our technology has tremendous potential to treat other diseases that cause blindness, and treat millions of patients," says Dr. Daphne Haim-Langford, who suffers from Uveitis and founded Tarsier Pharma
The Israeli startup treating the silent thief of sight
30.01.22
|
Yafit Ovadia
BELKIN Vision is using an automated laser procedure to tackle glaucoma, a disease that can lead to irreversible blindness
Ophthalmic Sciences unveils world's first AI contactless device for measuring eye fluid pressure
05.12.21
|
CTech
The device combines artificial intelligence in a virtual reality-like headset, enabling tele-diagnosis and monitoring for glaucoma. The company has begun steps toward FDA approval, and is raising funds to reach additional markets
BioLight to partner with Ichilov Medical Center to develop innovative ophthalmology technologies
29.11.21
|
CTech
According to the terms of the agreement, the company will retain the primary right to license technologies developed at Ichilov